Troels Peter Troelsen

Direktor/Vorstandsmitglied bei ABACUS MEDICINE A/S

Vermögen: 770 706 $ am 30.04.2024

78 Jahre

22 Beziehungen

Health Technology

Finance

Distribution Services

Aktive Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Flemming Wagner	M	-	ABACUS MEDICINE A/S	20 Jahre
Soren Nielsen	M	-	Reponex Pharmaceuticals A/S Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million. AKI Therapeutics ApS AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016.	-
Christian Vinding Thomsen	M	-	AKI Therapeutics ApS AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016. Reponex Pharmaceuticals A/S Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million.	3 Jahre
Peter Morch Eriksen	M	64	Reponex Pharmaceuticals A/S Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million.	-
Michael Vilhelmsen	M	-	ABACUS MEDICINE A/S	6 Jahre
Mogens Hobolth	M	-	ABACUS MEDICINE A/S	-
Troels Ring	M	-	AKI Therapeutics ApS AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016.	-
Mark Johnston	M	-	ABACUS MEDICINE A/S	5 Jahre
Lene Bech McCormick	F	-	ABACUS MEDICINE A/S	9 Jahre
Ole Lindhardt	M	-	ABACUS MEDICINE A/S	7 Jahre
Nick Nyborg	M	-	ABACUS MEDICINE A/S	-
Kasper Yde	M	-	ABACUS MEDICINE A/S	-
Anders Kunze Bønding	M	59	ABACUS MEDICINE A/S	5 Jahre
Frederik Heupel	M	-	ABACUS MEDICINE A/S	-
Michala Fischer-Hansen	F	-	ABACUS MEDICINE A/S	3 Jahre
Lars V. Jenster	M	-	ABACUS MEDICINE A/S	-
Jens Albert Harsaae	M	-	ABACUS MEDICINE A/S	5 Jahre
Niels Smedegaard	M	61	ABACUS MEDICINE A/S	4 Jahre
Lars Otto Uttenthal	M	79	AKI Therapeutics ApS AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016.	-
Charlotte Pahl	F	-	Reponex Pharmaceuticals A/S Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million.	-